Skip to main content
SpringerLink
Log in

Prevention of Recurrent Stroke

  • Chapter
Prevention of Stroke

Abstract

Cerebrovascular disease (CVD) is the third leading cause of death in the developed world and represents a major cause of disability in the aged. In the United States, CVD ranks as the eighth cause of years of potential life lost before age 65.1 The 1989 edition of a popular brochure “Stroke Facts” states: “In America someone dies of cardiovascular disease every 32 seconds. In 1986 nearly one out of two Americans died of heart and vascular disease; stroke claimed 147,000 lives in 1986. Stroke accounts for half of all patients hospitalized for acute neurological disease. Stroke related health care in 1989 is estimated by the American Heart Association at 13.5 billion dollars.” Detailed, accurate knowledge of the natural history of stroke, its incidence, and management is required to predict outcome and evaluate treatment.

When meditating over a disease, I never think of finding a remedy for it, but instead, a means of preventing it.

Louis Pasteur

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Center of Disease Control. Premature mortality due to cerebrovascular disease — United States, 1983. JAMA. 1987;258:182.

    Article  Google Scholar 

  2. Dyken ML, Wolf PA, Barnett HJM, et al. Risk factors in stroke, a statement for physicians by the subcommittee on risk factors and stroke of the stroke council. Stroke. 1984;15:1105–1111.

    Article  Google Scholar 

  3. Whisnant JP. The role of the neurologist in the decline of stroke. Ann Neurol. 1983;14:1–7.

    Article  PubMed  CAS  Google Scholar 

  4. Whisnant JP. The decline of stroke. Stroke. 1984; 15:160–168.

    Article  PubMed  CAS  Google Scholar 

  5. Garraway WM, Whisnant JP. The changing pattern of hypertension and the declining incidence of stroke. JAMA. 1987;258:214–217.

    Article  PubMed  CAS  Google Scholar 

  6. Hachinski V. Decreased incidence and mortality of stroke. Stroke. 1984;15:376–378.

    Article  PubMed  CAS  Google Scholar 

  7. Howard G, Toole JF, Becker C, et al. Changes in survival following stroke in five North Carolina counties observed during different periods. Stroke. 1989;20:345–350.

    Article  PubMed  CAS  Google Scholar 

  8. Ahmed OI, Orchard TJ, Sharma R, et al. Declining mortality from stroke in Allegheny County, Pennsylvania. Trends in case fatality and severity of disease, 1971–1980. Stroke. 1988;19:181–184.

    Article  PubMed  CAS  Google Scholar 

  9. Baum HM, Robins M. National Survey of Stroke. Survival and prevalence. Stroke. 1981;12(suppl 1):59–68.

    Google Scholar 

  10. Cooper SE. Stroke mortality declines; still major health problem. JAMA. 1984;252:594.

    Article  Google Scholar 

  11. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970–1985. Stroke. 1990; 21:989–992.

    Article  PubMed  CAS  Google Scholar 

  12. Epstein L, Zaaroor M. Mortality from ischemic heart disease and cerebrovascular disease in Israel 1969 – 1978. Stroke. 1982;13:570–573.

    Article  PubMed  CAS  Google Scholar 

  13. Pisa Z, Uemurat K. Trends in mortality from ischemic heart disease and other cardiovascular disease in 27 countries. World Health State Q. 1982;35:11–49.

    CAS  Google Scholar 

  14. Dyken ML. ‘Natural’ history of ischemic stroke. In: Cerebral Vascular Disease, eds MJG Harrison and ML Dyken, Butterworths, London, 1983, pp 139–170.

    Google Scholar 

  15. Chambers BR, Norris JW, Shurvell BL, et al. Prognosis of acute stroke. Neurology. 1987;37:221–225.

    Article  PubMed  CAS  Google Scholar 

  16. Sacco RL, Wolf PA, Kannel WB, et al. Survival and recurrence following stroke, the Framingham study. Stroke. 1982;13:290–295.

    Article  PubMed  CAS  Google Scholar 

  17. Terent A. Increasing incidence of stroke among Swedish women. Stroke. 1988;19:598–603.

    Article  PubMed  CAS  Google Scholar 

  18. Leonberg SC, Elliott FA. Prevention of recurrent stroke. Stroke. 1981;12:731–735.

    Article  PubMed  Google Scholar 

  19. Meissner I, Whisnant JP, Garraway WM. Hypertension management and stroke recurrence in community (Rochester, Minnesota, 1950–1979). Stroke. 1988;19:459–463.

    Article  PubMed  CAS  Google Scholar 

  20. Schmidt EV, Smirnov VE, Ryabova VS. Results of the seven-years prospective study of stroke patients. Stroke. 1988;19:942–949.

    Article  Google Scholar 

  21. Matsumoto N, Whisnant JP, Kurland LT, et al. Natural history of stroke in Rochester, Minnesota, 1955 through 1969: an extension of a previous study, 1945 through 1954. Stroke. 1973;4:20–29.

    Article  PubMed  CAS  Google Scholar 

  22. Baker RN, Schwartz WS, Ramseyer JC. Prognosis among survivors of ischemic stroke. Neurology. 1968;18:933–941.

    Article  PubMed  CAS  Google Scholar 

  23. Viitanen M, Eriksson S, Asplund K. Risk of recurrent stroke, myocardial infarction and epilepsy during long-term follow-up after stroke. Eur Neurol. 1988;28:227–731.

    Article  PubMed  CAS  Google Scholar 

  24. Homer D, Whisnant JP, Schoenberg BS. Trends in the incidence rates of stroke in Rochester, Minnesota, since 1935. Ann Neurol. 1987;22:245–251.

    Google Scholar 

  25. Sobel E, Alter M, Davanipour Z, et al. Stroke in the Lehigh valley: combined risk factors for recurrent ischemic stroke. Neurology. 1989;39:669–672.

    Article  PubMed  CAS  Google Scholar 

  26. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA. 1974;229:409–418.

    Article  Google Scholar 

  27. Beevers DG, Hamilton M, Fairmant MJ, et al. Antihypertensive treatment and the course of established cerebral vascular disease. Lancet. 1973;1:1407–1409.

    Article  PubMed  CAS  Google Scholar 

  28. Davis PH, Dambtosia JM, Schoenberg BS, et al. Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota. Ann Neurol. 1987;22:319–327.

    Article  PubMed  CAS  Google Scholar 

  29. Alter M, Sobel E, McCoy RL, et al. Stroke in the Lehigh valley: Risk factors for recurrent stroke. Neurology. 1987;37:503–507.

    Article  PubMed  CAS  Google Scholar 

  30. Solzi P, Ring H, Najenson T, Luz Y. Hemiplegic after a first stroke: Late survival and risk factors. Stroke. 1983;14:703–709.

    Article  PubMed  CAS  Google Scholar 

  31. Landi G, Barbarotto R, Morabito A, et al. Prognostic significance of fibrinopeptide A in survivors of cerebral infarction. Stroke. 1990;21:424–427.

    Article  PubMed  CAS  Google Scholar 

  32. Sacco RL, Foulkes MA, Mohr JP, et al. Determinants of early recurrence of cerebral infarction, the Stroke Data Bank. Stroke. 1989;20:983–989.

    Article  PubMed  CAS  Google Scholar 

  33. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299:53–59.

    Article  Google Scholar 

  34. Bousser MG, Eschwege E, Hagenau M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischaemia. Stroke. 1983;14:5–14.

    Article  PubMed  CAS  Google Scholar 

  35. UKTIA Study Group. United Kingdom transient ischaemic attack (UKTIA) aspirin trial: interim results. Br Med J. 1988;296:316–320.

    Article  Google Scholar 

  36. Sze PC, Reitman D, Pincus MM, et al. Antiplatelet agents in the secondary prevention of stroke: metaanalysis of randomized controlled trials. Stroke. 1988;19:436–442.

    Article  PubMed  CAS  Google Scholar 

  37. Antiplatelet Trialists Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J. 1988;296:320–331.

    Article  Google Scholar 

  38. The Dutch TIA Study Group. The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. Stroke. 1988;19:512–517.

    Article  Google Scholar 

  39. ESPS Group. European Stroke Prevention Study. Stroke. 1990;21:1122–1130.

    Article  Google Scholar 

  40. Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;1:1215–1220.

    Article  PubMed  CAS  Google Scholar 

  41. Ostrander LD, Jr., Brandt RL, Kjelsberg MO, et al. Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan. Circulation. 1965; 31:888–898.

    Article  PubMed  Google Scholar 

  42. Cardiogenic Brain Embolism. The second report of the cerebral embolism task force. Arch Neurol. 1989;46:727–743.

    Article  Google Scholar 

  43. Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke. 1988;19: 937–941.

    Article  PubMed  CAS  Google Scholar 

  44. Wolf PA, Kannel WB, McGee DL, et al. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke. 1983;14:664–667.

    Article  PubMed  CAS  Google Scholar 

  45. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major contribution to stroke in the elderly. Arch Intern Med. 1987;147:1561–1564.

    Article  PubMed  CAS  Google Scholar 

  46. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol. 1986;43:71–84.

    Article  Google Scholar 

  47. Kelley RE, Berger JR, Alter M, et al. Cerebral ischemia and atrial fibrillation: prospective study. Neurology. 1984;34:1285–1291.

    Article  PubMed  CAS  Google Scholar 

  48. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation, the Framingham study. N Engl J Med. 1982;306:1018–1022.

    Article  PubMed  CAS  Google Scholar 

  49. Lodder J, Dennis MS, Van Raak L, et al. Cooperative study on the value of long term anticoagulation in patients with stroke and non-rheumatic atrial fibrillation. Br Med J. 1988;296:1435–1438.

    Article  CAS  Google Scholar 

  50. Petersen P, Boysen G, Godtfredsen J, et al. Placebocontrolled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet. 1989;175–179.

    Google Scholar 

  51. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med. 1990;322:863–868.

    Google Scholar 

  52. The Boston Area Anticoagulation Trial for Atrial Fibrillation. The effects of low dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med. 1990;323:1505–1511.

    Article  Google Scholar 

  53. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial. N Engl J Med. 1985;313:1191–1200.

    Article  Google Scholar 

  54. Eastcott HHG, Pickering GW, Rob CG. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet. 1954;2:994–996.

    Article  Google Scholar 

  55. Pokras R, Dyken ML. Dramatic changes in the performance of endarterectomy for diseases of the extracranial arteries of the head. Stroke. 1988;19: 1289–1290.

    Article  PubMed  CAS  Google Scholar 

  56. Fields WS, Maslenikov V, Meyer JS, et al. Joint study of extracranial arterial occlusion. JAMA. 1970;211:1993–2003.

    Article  PubMed  CAS  Google Scholar 

  57. Shaw DA, Venables GS, Cartlidge NEF, et al. Carotid endarterectomy in patients with transient cerebral ischemia. J Neurol Sci. 1984;64:45–53.

    Article  PubMed  CAS  Google Scholar 

  58. Winslow CM, Solomon DH, Chassin MR, et al. The appropriateness of carotid endarterectomy. N Engl J Med. 1988;318:721–727.

    Article  PubMed  CAS  Google Scholar 

  59. Beebe HG, Clagett GP, DeWeese JA, et al. Assessing risk associated with carotid endarterectomy. A statement for health professionals by an Ad Hoc Committee on Carotid Surgery Standards of the Stroke Council, American Heart Association. Stroke. 1989;20:314–315.

    Google Scholar 

  60. American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Interim assessment: carotid endarterectomy. Neurology. 1990;40:682–683.

    Article  Google Scholar 

  61. Committee on Health Care Issues, American Neurological Association. Does carotid endarterectomy decrease stroke and death in patients with transient ischemic attacks? Ann Neurol. 1987; 22:72–76.

    Article  Google Scholar 

  62. Caplan LR. Carotid-artery disease. N Engl J Med. 1986;315:886–887.

    Article  PubMed  CAS  Google Scholar 

  63. Callow AD, Caplan LR, Correll JW, et al. Carotid endarterectomy: what is its current status? Am J Med. 1988;85:835–838.

    Article  PubMed  CAS  Google Scholar 

  64. Barnett HJM, Plum F, Walton JN. Carotid endarterectomy-an expression of concern. Stroke. 1984;15: 941–943.

    Article  PubMed  CAS  Google Scholar 

  65. Califano JA Jr. Billions blown on health. New York Times; 12 April 1989.

    Google Scholar 

  66. Lundtyke MA. Physician-inform thyself. New York Times; 16 April 1989.

    Google Scholar 

  67. Thompson JE. Don’t throw out the baby with the bath water. A perspective on carotid endarterectomy. J Vasc Surg. 1986;4:543–545.

    PubMed  CAS  Google Scholar 

  68. Robins M, Baum HM. Incidence. National Survey of Stroke. Stroke. 1981;12 (suppl 1):1–45–55.

    Article  Google Scholar 

  69. Cooper R, Hsieh SC. Slowdown in the decline of stroke mortality in the United States, 1978–1986. Stroke 1990;21:1274–1279.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. N. M. Bornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. D. Korczyn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, M4N 3M5, Canada

    John W. Norris M.D.

  2. Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, N6A 5A5, Canada

    Vladimir C. Hachinski M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bornstein, N.M., Korczyn, A.D. (1991). Prevention of Recurrent Stroke. In: Norris, J.W., Hachinski, V.C. (eds) Prevention of Stroke. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4226-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4226-8_21

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-4228-2

  • Online ISBN: 978-1-4757-4226-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation